pipette
ESEspañol

Revised estimates of types and duration of long COVID symptoms based on claims records from 245 million US patients

Hamed Nilforoshan, Julia Reisler, Erfan Jahanparast, Michael Moor, Steven N. Goodman, Stefan Wager, Jure Leskovec

Peer-reviewed journalBroad interest

In the authors' words

COVID-19 has been reported to cause multisystem effects lasting years [Z. Al-Aly, E. Topol, Science 383, 830-832 (2024)]. These findings are primarily based on cohort studies comparing test-positive COVID-19 patients to controls without known COVID-19 infection, tested or untested [M. Cai, Y. Xie, E. J. Topol, Z. Al-Aly, Nat. Med. 30, 1564-1573 (2024)]. However, such comparisons can be biased by the reasons people were tested. Using 14.4 billion insurance claims from 244.7 million US patients, we find that most long-term effects attributed to COVID-19 by unrestricted control designs likely reflect bias due to selective testing of individuals with non-COVID conditions, causing long-term effects of those conditions to be misattributed to COVID-19. We removed this bias by analyzing only tested individuals, comparing test-positive to test-negative patients. Across 614 clinical outcomes followed over 2 y, the test-based design resulted in 83.5% fewer symptoms being attributable to COVID-19 between 30 to 119 d after infection (43 attributable symptoms vs. 262 for the unrestricted control design), a 98.2% reduction at 120 to 359 d (5 vs. 286), and a 100% reduction at 360 to 719 d (0 vs. 369). The unrestricted control design also attributed unrelated outcomes (e.g., firearm injuries) to COVID-19 at a high rate, whereas the testing-based design did not. The test-based control design may modestly underestimate some effects. This study does not indicate that symptoms beyond one year are not genuine but that their attributability to COVID-19 is uncertain.

Main resultLimitation the authors admit

In plain words AI summary

The authors analyzed 14.4 billion insurance claims from 244.7 million US patients. They found that common study designs comparing COVID-positive patients to untested controls likely overcount long COVID symptoms. When they compared only tested patients, 83.5% fewer symptoms were tied to COVID-19 at 30-119 days, and 100% fewer at 360-719 days. The stricter method may slightly underestimate some effects. The authors do not claim symptoms beyond one year are fake, only that their link to COVID-19 is unclear.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.

Appeared: Thursday, October 29. Proceedings of the National Academy of Sciences. Peer-reviewed journal.

DOI: 10.1073/pnas.2604414123